西他列汀与2型糖尿病患者心力衰竭风险：一项荟萃分析。 - Suppr

Sitagliptin and Risk of Heart Failure in Patients With Type 2 Diabetes: A Meta-Analysis.

作者信息

Krittanawong Chayakrit, Kitai Takeshi, Aydar Mehmet, Sun Tao

出版信息

JACC Heart Fail. 2016 Nov;4(11):910. doi: 10.1016/j.jchf.2016.07.005.

DOI:10.1016/j.jchf.2016.07.005

PMID:27810084

Abstract

摘要

相似文献

Sitagliptin and Risk of Heart Failure in Patients With Type 2 Diabetes: A Meta-Analysis.

JACC Heart Fail. 2016 Nov;4(11):910. doi: 10.1016/j.jchf.2016.07.005.

[Dipeptidyl peptidase 4 inhibitors and the risk of cardiovascular disease: The case of sitagliptin].

Semergen. 2016 Jul-Aug;42(5):329-30. doi: 10.1016/j.semerg.2015.09.011. Epub 2015 Oct 29.

Chronic dipeptidyl peptidase-4 inhibition with sitagliptin is associated with sustained protection against ischemic left ventricular dysfunction in a pilot study of patients with type 2 diabetes mellitus and coronary artery disease.

Circ Cardiovasc Imaging. 2014 Mar;7(2):274-81. doi: 10.1161/CIRCIMAGING.113.000785. Epub 2014 Feb 6.

Do dipeptidyl peptidase IV (DPP-IV) inhibitors cause heart failure?

Clin Ther. 2014 Dec 1;36(12):2072-2079. doi: 10.1016/j.clinthera.2014.10.009. Epub 2014 Nov 13.

Sitagliptin--another option for managing type 2 diabetes in dialysis patients?

Am J Kidney Dis. 2013 Apr;61(4):532-5. doi: 10.1053/j.ajkd.2013.01.004.

[Hypoglycemia in the diabetes treatment - risk minimization with dipeptidyl peptidase-4 inhibitors].

Drugs Today (Barc). 2010 Dec;46 Suppl F:1-12.

Do dipeptidyl peptidase-4 inhibitors increase the risk of heart failure?

JACC Heart Fail. 2014 Dec;2(6):583-5. doi: 10.1016/j.jchf.2014.05.005. Epub 2014 Jul 2.

Sitagliptin: a viewpoint by Mark S. Kipnes.

Drugs. 2007;67(4):598-9. doi: 10.2165/00003495-200767040-00009.

Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus: Secondary Analysis of a Randomized Clinical Trial.

JAMA Cardiol. 2016 May 1;1(2):126-35. doi: 10.1001/jamacardio.2016.0103.

Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System.

Nutr Metab Cardiovasc Dis. 2016 May;26(5):380-6. doi: 10.1016/j.numecd.2016.02.006. Epub 2016 Feb 19.

引用本文的文献

Sitagliptin, diabetes mellitus, and heart failure: an in-depth review of sitagliptin therapy and heart failure in patients with diabetes mellitus.

Diabetol Int. 2025 Feb 15;16(2):237-256. doi: 10.1007/s13340-025-00800-6. eCollection 2025 Apr.

DPP-4 inhibitors and heart failure: a potential role for pharmacogenomics.

Heart Fail Rev. 2018 May;23(3):355-361. doi: 10.1007/s10741-017-9655-y.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Sitagliptin and Risk of Heart Failure in Patients With Type 2 Diabetes: A Meta-Analysis.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献